Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)
Ridker, Paul M, MD, Thuren, Tom, MD, Zalewski, Andrew, MD, Libby, Peter, MD
Published in The American heart journal (01.10.2011)
Published in The American heart journal (01.10.2011)
Get full text
Journal Article
Diacylglycerol Acyltransferase 1 (DGAT1) Inhibition as a Metabolic Regulator: Clinical Benefits of Pradigastat in Obese Patients with Type 2 Diabetes
Kjems, Lise, MD, PhD, Meyers, Charles, MD, Thuren, Tom, MD, PhD
Published in Journal of clinical lipidology (01.05.2014)
Published in Journal of clinical lipidology (01.05.2014)
Get full text
Journal Article